Abstract

Intravitreal and periocular injections are increasingly applied for the treatment of a wide variety of retinal and uveal diseases, including age-related macular degeneration, diabetic retinopathy, retinal vascular occlusions, and uveitis. Despite promising results in stopping or slowing disease progression and improving visual acuity, intravitreal injection of anti-VEGF agents and corticosteroids may be associated with systemic side effects and serious ocular complications. In this review, we aim to provide an overview of the complications of intravitreal, subconjunctival and subtenon injection applications.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call